Rigel Pharmaceuticals, Inc. (RIGL) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 770.38M |
| Enterprise Value | 783.11M |
| P/E Ratio | 2.6 |
| PEG Ratio | 0.01 |
| Price/Sales Ratio | 3.07 |
| Price/Book Ratio | 2 |
| Enterprise/Revenue | 2.99 |
| Enterprise/EBITDA | 8.81 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | 1.16 |
| Operating Margin | 0.31 |
| Return On Assets | 0.62 |
| Return On Equity | 0.96 |
| Revenue | 294.28M |
| Revenue/Share | 14.93 |
| Gross Profit | 274.66M |
| EBITDA | 131.56M |
| Net Income | 367.02M |
| Diluted EPS | 19.48 |
| Total Cash | 95.33M |
| Total Cash/Share | 5.14 |
| Total Debt | 39.95M |
| Total Debt/Equity | 0.09 |
| Current Ratio | 1.95 |
| Book Value Per Share | 22.96 |
| 52-Week Change | 10.58 |
| 52-Week High | 52.24 |
| 52-Week Low | 24.95 |
| Moving Average 50 Days | 39.26 |
| Moving Average 200 Days | 35.9 |
| Average Volume | 361,227 |
| Shares Outstanding | 18.5M |
| % Held by Institutions | 89.82 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
| Last Split Date | June 27, 2024 |